Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
Medtronic
Merck
McKinsey
Mallinckrodt
Harvard Business School

Last Updated: October 23, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Trehalose

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Trehalose: Patents, clinical trial progress, indications

Trehalose is an investigational drug.

There have been 7 clinical trials for Trehalose. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2016.

The most common disease conditions in clinical trials are Macular Edema, Fatty Liver, and Edema. The leading clinical trial sponsors are National Institute for Medical Research Development, Genentech, Inc., and Mashhad Razavi Hospital.

There are two US patents protecting this investigational drug and thirty-six international patents.

Recent Clinical Trials for Trehalose
TitleSponsorPhase
Inflammation Reduction by TREhalose AdminisTrationMashhad Razavi HospitalPhase 2
Inflammation Reduction by TREhalose AdminisTrationNational Institute for Medical Research DevelopmentPhase 2
Inflammation Reduction by TREhalose AdminisTrationMashhad University of Medical SciencesPhase 2

See all Trehalose clinical trials

Clinical Trial Summary for Trehalose

Top disease conditions for Trehalose
Top clinical trial sponsors for Trehalose

See all Trehalose clinical trials

US Patents for Trehalose

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Trehalose   Start Trial Fragrance composition GIVAUDAN SA (Vernier, CH)   Start Trial
Trehalose   Start Trial Salt of cephalosporin derivative, its crystalline solid and a method of manufacturing thereof Shionogi & Co., Ltd. (Osaka, JP)   Start Trial
Trehalose   Start Trial Fibrinogen preparations enriched in fibrinogen with an extended alpha chain Mallinckrodt Pharma IP Trading D.A.C. (Dublin, IE)   Start Trial
Trehalose   Start Trial M.tuberculosis vaccines Statens Serum Institut (Copenhagen S, DK)   Start Trial
Trehalose   Start Trial Compositions and methods for inhibition of the JAK pathway Rigel Pharmaceuticals, Inc. (South San Francisco, CA)   Start Trial
Trehalose   Start Trial Double-acylated GLP-1 derivatives Novo Nordisk A/S (Bagsvaerd, DK)   Start Trial
Trehalose   Start Trial Method of reducing blood glucose by administering RON agonists GENENTECH, INC. (South San Francisco, CA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Trehalose

Drugname Country Document Number Estimated Expiration Related US Patent
Trehalose Brazil PI0610537 2025-04-04   Start Trial
Trehalose Canada 2601172 2025-04-04   Start Trial
Trehalose China 101184389 2025-04-04   Start Trial
Trehalose European Patent Office 1865763 2025-04-04   Start Trial
Trehalose Spain 2392731 2025-04-04   Start Trial
Trehalose Japan 2008538191 2025-04-04   Start Trial
Trehalose Japan 5624719 2025-04-04   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
Merck
Mallinckrodt
Baxter
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.